4880 Share Price | CellSource Co., Ltd. Stock Analysis & Recommendation

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

Compare CellSource Co., Ltd. with Similar Stocks

Elan Corp.ASKA Pharmaceutical Holdings Co., Ltd.Katakura Industries Co., Ltd.

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Dashboard

Flat results in Jul 26

NET PROFIT(HY) At JPY 84.26 MM has Grown at -34.17%
INVENTORY TURNOVER RATIO(HY) Lowest at 4.73 times
NET SALES(Q) Lowest at JPY 781.88 MM

With ROE of 2.03%, it has a very attractive valuation with a 0.99 Price to Book Value

Consistent Underperformance against the benchmark over the last 3 years

Mojo Parameters

Stock DNA

Industry

Pharmaceuticals & Biotechnology

Market cap

JPY 6,530 Million (Micro Cap)

P/E

49.00

Industry P/E

Dividend Yield

0.00%

Debt Equity

-0.80

Return on Equity

2.03%

Price to Book

1.09

Revenue and Profits:

Net Sales:

782 Million

(Quarterly Results - Jul 2026)

Net Profit:

103 Million

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

3.19%

6 Months

-22.17%

1 Year

-44.79%

2 Years

-74.26%

3 Years

-85.95%

4 Years

-92.77%

5 Years

-98.37%

CellSource Co., Ltd. for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

No Recent News for the Company

Announcements

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

9.66%

EBIT Growth (5y)

-15.79%

EBIT to Interest (avg)

100.00

Debt to EBITDA (avg)

Net Debt to Equity (avg)

-0.74

Sales to Capital Employed (avg)

0.68

Tax Ratio

63.77%

Dividend Payout Ratio

929.37%

Pledged Shares

Institutional Holding

ROCE (avg)

89.35%

ROE (avg)

16.26%

Valuation key factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

0.99

EV to EBIT

4.10

EV to EBITDA

2.40

EV to Capital Employed

0.94

EV to Sales

0.31

PEG Ratio

0.17

Dividend Yield

ROCE (Latest)

22.83%

ROE (Latest)

2.03%

Technicals key factors

Indicator

Weekly

Monthly

MACD

Mildly Bullish

RSI

No Signal

Bullish

Bollinger Bands

Mildly Bearish

Bearish

Moving Averages

Bearish (Daily)

KST

Mildly Bullish

Dow Theory

No Trend

Mildly Bullish

OBV

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot

No data for shareholding present.

Shareholding Compare (%holding)

No data for shareholding present.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jul'26 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Jul 2026 is -14.60% vs 6.47% in Apr 2026",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Jul 2026 is 174.73% vs 11.90% in Apr 2026",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Jul'26",
        "Apr'26",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "781.90",
          "val2": "915.60",
          "chgp": "-14.60%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "98.70",
          "val2": "110.60",
          "chgp": "-10.76%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.20",
          "val2": "0.20",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "68.60",
          "val2": "-0.70",
          "chgp": "9,900.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "103.30",
          "val2": "37.60",
          "chgp": "174.73%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "68.40%",
          "val2": "72.20%",
          "chgp": "-0.38%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Oct'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Oct 2025 is -14.78% vs -3.45% in Oct 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Oct 2025 is -95.50% vs -74.23% in Oct 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Oct'25",
        "Oct'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "3,711.50",
          "val2": "4,355.10",
          "chgp": "-14.78%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "371.00",
          "val2": "282.40",
          "chgp": "31.37%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "1.30",
          "val2": "1.40",
          "chgp": "-7.14%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-38.20",
          "val2": "10.20",
          "chgp": "-474.51%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "10.70",
          "val2": "237.90",
          "chgp": "-95.50%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "44.90%",
          "val2": "29.70%",
          "chgp": "1.52%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]